{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:55:32Z","timestamp":1787241332977,"version":"build-2736575974"},"reference-count":14,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":274,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Immunol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/cei.12517","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T07:43:26Z","timestamp":1419839006000},"page":"70-71","source":"Crossref","is-referenced-by-count":9,"special_numbering":"supplement S1","title":["Effective dosing strategies for therapeutic immunoglobulin: managing wear-off effects in antibody replacement to immunomodulation"],"prefix":"10.1093","volume":"178","author":[{"given":"S. A.","family":"Misbah","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology; Oxford University Hospitals; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,29]]},"reference":[{"key":"10.1111\/cei.12517-BIB0001|cei12517-cit-0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodefi ciency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1111\/cei.12517-BIB0002|cei12517-cit-0002","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10875-011-9546-2","article-title":"Incidence of infection is inversely related to steady-state (trough) serum IgG level in studies of subcutaneous IgG in PIDD","volume":"31","author":"Berger","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1111\/cei.12517-BIB0003|cei12517-cit-0003","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0091-6749(99)70085-0","article-title":"Pulmonary abnormalities in patients with primary hypogammaglobulinemia","volume":"104","author":"Kainulainen","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/cei.12517-BIB0004|cei12517-cit-0004","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/cei.12517-BIB0005|cei12517-cit-0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cei.12172","article-title":"The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012","volume":"175","author":"Edgar","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/cei.12517-BIB0006|cei12517-cit-0006","doi-asserted-by":"crossref","first-page":"AB193","DOI":"10.1016\/j.jaci.2011.12.286","article-title":"Increased frequency of infections at the end of the IVIG dosing cycle: effect of characterization from three phase III studies","volume":"129","author":"Bexon","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/cei.12517-BIB0007|cei12517-cit-0007","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2008.04.044","article-title":"Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection","volume":"122","author":"Bonagura","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/cei.12517-BIB0008|cei12517-cit-0008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1529-8027.2011.00323.x","article-title":"CIDP\u2009-\u2009the relevance of recent advances in Schwann cell\/axonal neurobiology","volume":"16","author":"Pollard","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1111\/cei.12517-BIB0009|cei12517-cit-0009","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10072-010-0352-z","article-title":"Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report","volume":"31","author":"Dacci","year":"2010","journal-title":"Neurol Sci"},{"key":"10.1111\/cei.12517-BIB0010|cei12517-cit-0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1529-8027.2011.00330.x","article-title":"A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study","volume":"16","author":"Misbah","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1111\/cei.12517-BIB0011|cei12517-cit-0011","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jnnp-2012-304670","article-title":"Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy","volume":"84","author":"Kuitwaard","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/cei.12517-BIB0012|cei12517-cit-0012","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1111\/cei.12517-BIB0013|cei12517-cit-0013","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1529-8027.2006.00105.x","article-title":"Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy","volume":"11","author":"Rajabally","year":"2006","journal-title":"J Peripher Nerv Syst"},{"key":"10.1111\/cei.12517-BIB0014|cei12517-cit-0014","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3810\/pgm.2013.03.2619","article-title":"Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disorders","volume":"125","author":"Broyles","year":"2013","journal-title":"Postgrad Med"}],"container-title":["Clinical & Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12517","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/cei.12517\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:27:33Z","timestamp":1641036453000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cei.12517"}},"subtitle":["Ig dosing strategies"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":14,"URL":"https:\/\/doi.org\/10.1111\/cei.12517","archive":["Portico"],"relation":{},"ISSN":["0009-9104"],"issn-type":[{"value":"0009-9104","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}